The impact of treatment modality on infection-related hospitalization rates in perit oneal dialysis and hemodialysis patients

Peritoneal Dialysis International

Volumn 31, Issue 4, 2011, Pages 440-449

  Williams, Victoria R ^a   Quinn, Robert ^a   Callery, Sandra ^a   Kiss, Alex ^a   Oliver, Matthew J ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

End stage renal disease; Hemodialysis; Hospitalization; Infection

Indexed keywords

AGED; BACTEREMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION COMPLICATION; INFECTION RATE; INFECTION RISK; INTERMETHOD COMPARISON; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TERTIARY HEALTH CARE; THERAPY EFFECT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; HOSPITALIZATION; MICROBIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS;

AGED; BACTEREMIA; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; PERITONEAL DIALYSIS; PERITONITIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84855177084     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00224     Document Type: Review

References (46)

1. Vanholder R, VanBiesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20:477-80.
2. US Renal Date System. USRDS 2008 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
3. US Renal Date System. USRDS 2007 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
4. Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complication between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 2006; 1:1226-33.
5. Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 2007; 18:952-9.
6. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999; 55:1081-90.
7. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184-91.
8. Schaubel DE, Blake PG, Fenton SS. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int 2001; 60:1517-24.
9. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32:155-60.
10. Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC, et al. Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 2008; 21:24-8.
11. Oliver MJ, Garg AX, Blake PG, Johnson JF, Verrelli M, Zacharias JM, et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant [in press]. Epub 25 Feb 2010 as doi:10.1093/ndt/gfq085.
12. Horan TC, Gaynes RP. Surveillance of nosocomial infections: CDC definitions of nosocomial infections. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: lippincott Williams & Wilkins; 2004: 1659-702.
13. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002; 51(RR10):1-26.
14. Infection control guideline: preventing infections associated with indwelling intravascular access devices. Can Commun Dis Rep 1997; 23(Suppl 8):i-iii, 1-32, i-iv, 1-16.
15. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
16. Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM, et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 2002; 91:399-405.
17. Holley JL, Bernardini J, Perlmutter JA, Piraino B. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis. Perit Dial Int 1994; 14:66-9.
18. Jaar BG, Hermann JA, Furth SL, Briggs W, Powe NR. Septicemia in diabetic hemodialysis patients: comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis 2000; 35:282-92.
19. Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 2009; 4:135-41.
20. Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41:664-9.
21. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors. Nephron 2007; 107:128-32.
22. Boelaert JR, Daneels RF, Schugers ML, Matthys EG, Gordts BZ, Van landuyt HW. Iron overload in hemodialysis patients increased the risk of bacteremia: a prospective study. Nephrol Dial Transplant 1990; 5:130-4.
23. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004; 43:891-9.
24. Little J, Irwin A, Marshall T, Rayner H, Smith S. Predicting a patient's choice of dialysis modality: experience in a United Kingdom renal department. Am J Kidney Dis 2001; 37:981-6.
25. Oliver MJ, Quinn RR, Richardson EP, Kiss AJ, Lamping DL, Manns BJ. Home care assistance and the utilization of peritoneal dialysis. Kidney Int 2007; 71:673-8.
26. Xue JL, Chen SC, Eben JP, Constantini EG, Everson SE, Frazier ET, et al. Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation. Kidney Int 2002; 61:734-40.
27. Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39:24-36.
28. Moist LM, Trpeski L, Na Y, Lok CE. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008; 3:1726-32.
29. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21:721-8.
30. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant 1995; 10:377-81.
31. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68:311-18.
32. Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15:1936-42.
33. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; (103):S55-62.
34. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18:261-70.
35. Casey M, Taylor J, Clinard P, Graham A, Mauck V, Spainhour L, et al. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20:566-8.
36. Wong SSH, Chu KH, Cheuk A, Tsang WK, Fung SKS, Chan HWH, et al. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 2003; 23(Suppl 2):S153-8.
37. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991; 40:934-8.
38. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae-a randomized controlled trial. J Hosp Infect 1990; 15:311-21.
39. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085-92.
40. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31:189-93.
41. Guo H, Liu J, Collins AJ, Foley RN. Pneumonia in incident dialysis patients-the United States Renal Data System. Nephrol Dial Transplant 2008; 23:680-6.
42. Bastani B, Minton J, Islam S. Insufficient penetration of systemic vancomycin into the PermCath lumen. Nephrol Dial Transplant 2000; 15:1035-7.
43. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127:275-80.
44. Keane GR, Bailie E, Boeschoten R, Gokal TA, Golper CJ, Holmes Y, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20:828-9]. Perit Dial Int 2000; 20:396-411.
45. Troidle L, Gorban-Brennan N, Finkelstein FO. Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis. Adv Perit Dial 2005; 21:98-101.
46. Szeto CC, Chow KM, Wong TY, Leung CB, Wang AY, Lui SF, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 2002; 13:1040-5.